Healthcare Reform
Risks to UK pharmaceutical spending from a US-UK free trade deal
A leaked document about UK-US free trade deal discussions back in 2017 has dominated UK media coverage over the past…
Germany’s fixed pricing for medicines faces European reckoning
Fixed prices for prescription medicines are an important part of the framework of pharmaceutical pricing and reimbursement regulation in Germany.…
Ten-year Medicare budget impact of increased coverage for anti-obesity intervention
Obesity rates have reached 37.5% and 39.4% among men and women age 60 and older by 2014, respectively, compared to…
South Korean pharma dreams struggle
In September, South Korean drugmaker Hanmi Pharmaceutical signed a collaboration agreement with US biotech Phanes Therapeutics focusing on dual- and…
Taking the pulse of international reference pricing
What a difference a year (or two) makes. When we published the 2017 edition of our International Reference Pricing Guidebook,…